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We have detected proteolytic processing of a form of exoglucanase representative of the endoplasmic reticulum (form A). This processing did not 
take place when form A was obtained from protoplasts lysed in the presence of either EDTA or leupeptin, two wel-characterixed inhibitors of 
KEX2 endoprotease from Sacchuromyces cerevisiae. Sequencing of the amino terminus of an A-like form of enzyme secreted by a kex2 mutant 
indicated the presence of 4 amino acids, with a pair of basic residues (Lys-Arg) at their carboxyl side, preceding the amino terminus of the wild-type 
external exoglucanase. 
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1. INTRODUCTION 
Maturation of many eukaryotic glycoproteins in- 
volves processing of both carbohydrate and protein 
moieties. Final carbohydrate composition confers im- 
portant physical as well as biological properties to the 
molecules [l]. On the other hand, proteolytic process- 
ing has been related to physiological regulation of many 
important processes 121. 
Proteolytic processing of precursors is well 
documented in yeast. Thus, many zymogenic precur- 
sors of vacuolar proteases are converted to the final ac- 
tive form by PEP4 protease, or protease A [3,4]. 
However, the best-studied examples of proteolytic pro- 
cessing in yeast concern the maturation of the glycopro- 
tein precursors of a-factor and killer toxin [S]. Central 
to the maturation of both precursors is the product of 
the KEX2 gene, an endoprotease located somewhere in 
the Golgi body [6,7]. The KEX2 protease cleaves on the 
carboxyl end of dibasic residues with the sequence X- 
Lys-Arg [8]. In addition to these naturally synthesized 
yeast products, the KEX2 protein also processed an 
amyloglucosidase from Aspergillus and pre-a-factor- 
somatostatin hybrids cloned in yeast [9,10]. 
oligosaccharides [13] whereas the minor one (ex- 
oglucanase I) adds an outer chain to at least one residue 
[ 121. In a previous report [14] we have described the 
presence of two ionic representatives of exoglucanase II
during its transport to the cell surface. At that time it 
was suggested that the transformation of one into the 
other could be due to the addition of phosphate to the 
carbohydrate moiety. In the present report we present 
evidence indicating that central to the transformation is 
a proteolytic cleavage, in a kexZdependent manner, of 
at least 4 residues at the NH2-terminus of the less acidic 
form. 
2. MATERIALS AND METHODS 
2. I. Microorganisms and culture conditions 
S. cerevisiue haploid strain X2180-1A and its derivative sec7, which 
is blocked in transport of secretory and plasma membrane proteins 
from Golgi body (and, accordingly, accumulates those proteins at the 
restrictive temperature of 37’C) were supplied by Dr Schekman 
(University of California, Berkeley). A kex2 mutant strain (Y Ural 
kex2-1 Argl His7 was kindly supplied by Dr de1 Rey (University of 
Salamanca, Spain). All these strains were grown in a synthetic 
medium 1151 with the appropriate supplement of growth factors. 
Saccharomyces cerevisiae secretes two exogluca- 
nases, which share a common protein portion but differ 
in their carbohydrate moieties [ 11,121. The major isoen- 
zyme (exoglucanase II) contains two short N-linked 
2.2. High-pressure liquid chromatography 
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For ion-exchange chromatography, dialyzed samples (20-100 #I) 
were applied to a Bio-Gel TSK DEAE-S-PW column (75 x 7.5 mm). 
The column was first washed with two column volumes of 0.2 M NaCl 
in 20 mM sodium acetate buffer, pH 5.2. Then, the enzymes were 
eluted with a linear gradient of NaCl(O.2-0.5 M) in the same buffer. 
Elution was performed at a flow rate of 0.5 ml/min and a pressure of 
12 bars. For gel filtration, 20-100~1 samples were applied to an Ultro- 
Pack TSK-G3000 SW (60 cm) column. They were eluted with 0.1 M 
of acetate buffer, pH 5.2, at a flow rate of 0.5 ml/min and at a 
pressure of 18 bars. 
Abbreviations: endo H, endo-b-N-acetylglucosaminidase H; PAGE, 
polyacrylamide gel electrophoresis; HPLC, high-pressure liquid 
chromatography; SDS, sodium dodecyl sulphate; pNPG, paranitro- 
phenol-B-D-glucoside 
2.3. Purification of enzymes 
Purification of the major external exoglucanase was performed as 
described before [1 11. An A-like form of enzyme [14] (see also section 
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00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 99 
Volume 268, number 1 FEBSLETTERS JuIy 1990 
3) was purified from the culture medium of exponentiaIly growing 
kex2 ceils. One peak of activity eiuted from the ion-exchange column 
(HPLC) at 0.23 M salt (the major external exoglucanase eiuted at 0.27 
M). The corresponding material was further purified by gel filtration 
(HPLC). 
2.4. Sequence determination 
The purified A-like form of exoglucanase (500 pmol) was sequenc- 
ed on polybrene-coated filters using an Applied Biosystems 477A 
microsequencer. The sequence of the purified major external ex- 
oglucanase will be reported in extent elsewhere [12]. 
2.5. Other methods 
Transformation of cells into protoplasts and enzymatic analyses us- 
ing pNPG as a substrate were performed as described [IS]. Pro- 
topfasts were tysed in 25 mM sodium acetate buffer, pH 5.2, contain- 
ing 10 mM sodium azide (lysis buffer). When indicated EDTA (10 
mM) or leupeptin (10 mM) were included in the lysis buffer. High- 
speed supernatants (soluble fractions) of protoplast lysates were ob- 
tained by centrifugation at 46000 rpm in a 70Ti Beckman rotor 
(120000xg). Standard endo H treatments (5 mU of endo H and 
about 15 U of exoglucanase ina final volume of 280~1) were perform- 
ed for 5 h in the presence of PMSF (1 mM) and pepstatin A (20pM). 
Immunoblots were performed as described [14]. 
3. RESULTS 
In a previous work we have described the presence of 
two ionic forms of the secretory yeast exoglucanase in- 
side the protoplast [14]. The less acidic form (form A) 
was typical from the endoplasmic reticulum (i.e. it was 
the major enzyme form accumulated by secl8 cells) 
whereas the most acidic one was present in both 
secretory vesicles (i.e. it was the predominant form ac- 
cumulated by secl) and culture medium. The transfor- 
mation of A into B appears to occur at the level of the 
Golgi complex, since sec7 cells accumulated similar 
amounts of both enzyme forms. Forms A and B were 
indistinguishable by SDS-PAGE; moreover, their 
deglycosylated (endo H-treated) products also com- 
igrated in the same system. 
Similar results were obtained when the analysis of the 
deglycosylation reaction was carried out by ion- 
exchange chromatography at high pressure. As shown 
in Fig. la, high-speed supernatants of sec7 cells that 
have accumulated secretory products at the non- 
permissive temperature gave two peaks of exoglucanase 
which represented 60% and 40% of the activity 
recovered from the column (909’0). As expected, the im- 
munoblot analysis revealed the presence of a single 
band that roughly co-migrated with the mature ex- 
oglucanase II [ 111. Treatment of the whole supernatant 
with endo H under standard conditions (see section 2) 
converted both peaks into a single one; the correspon- 
ding material not only eluted from the HPLC column at 
the same position as the in vitro deglycosylated external 
exoglucanase (Fig. lc) but also comigrated with it in 
SDS-PAGE [14]. Surprisingly, when sec7 protoplasts 
were lysed in the presence of EDTA, the analysis of the 
deglycosylated products (originated by endo H treat- 
ment of the high speed supernatant) in the ion-exchange 
100 
Tlrne (mln) 
Fig. I, Analysis of ionic forms of exoglucanase accumulated by sec7 
at the restrictive temperature. Sec7 cells were incubated at 37*C for 2 
h. Then they were transformed into protopIasts which were lysed in 
the lysis buffer (50 mM acetate buffer, pH 5.2) alone (a,b,c) or sup- 
plemented with EDTA (d) or leupeptin (e). High-speed supernatants 
were analyzed without further treatment (a) or after incubation at 
37°C for 5 h in the absence (b) or in the presence of endo H (c,d,e) 
as indicated in section 2. The resulting sampIes were applied in the ion 
exchange column (HPLC) and eluted as indicated in section 2. 
column indicated the presence of two (instead of a 
single one) peaks of activity (Fig. Id). Endo H treat- 
ment of isolated individual peaks (obtained in the 
presence of EDTA) indicated that peak B gave rise to 
the most acidic deglycosylated compound whereas peak 
A was the source of the less acidic counterpart (not 
shown). 
In order to gain information on the nature of forms 
A and B, their deglycosyiated products were subjected 
to immunoblot analysis. As shown in Fig. 2, degly- 
cosylated B appeared as a well-de~ned band (lane 2) 
that comigrated with the protein portion of the mature 
enzyme whereas deglycosylated A (lane 1) was 
heterogeneous: a well-defined front (running just 
behind deglycosylated B) was followed by a rather dif- 
fuse tail. The most likely explanation of all the above- 
mentioned results was that the protein portion of form 
A was converted into its counterparts of form B by an 
endoprotease(s) which is inactive when protoplasts are 
lysed in EDTA. Such a conversion also occurred by in- 
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Fig. 2. Immunoblot analysis of the isolated deglycosylated peaks A 
(lane 1) and B (lane 2) from Fig. Id. Upper arrow = secreted major ex- 
oglucanase and native forms A and B; lower arrow = deglycosylated 
exoglucanase. 
cubation of the isolated form A (obtained in the 
absence of EDTA) at 37°C in the absence of endo H, in- 
dicating that deglycosylation was not necessary for the 
action of the protease (Fig. lb). 
A good candidate for playing a role in the above- 
mentioned transformation was the KEX2 protein, 
which has been reported to be inhibited by EDTA [16]. 
That this could be the case was reinforced by the fact 
that leupeptin, another well-known inhibitor of the 
KEX2 endoprotease [16], prevented to a great extent, 
transformation of A into B (or their deglycosylated pro- 
ducts) during the deglycosylation reaction (Fig. le). 
If that is true, a mutant lacking the protease should 
secrete into the culture medium an exoglucanase with 
the ionic properties of form A. An A-like form was in- 
deed found in the growth medium of a kex2 mutant. 
This enzyme was purified by conventional methods us- 
ed by us in the purification of exoglucanases ([111, see 
section 2). Sequencing of the new protein indicated the 
presence of a group of 4 amino acids (Asn-Lys-Lys- 
Arg) preceding the amino-terminus of the wild-type 
mature protein (Fig. 3). It is noticeable that the extra- 
sequence contains 3 (out of 4) positively charged amino 
acids whose cleavage should account for the drastic 
change in the ionic behaviour of the molecule. In addi- 
tion, in support of our expectations adipeptide with the 
sequence Lys-Arg was found at the carboxyl end of the 
extra-peptide. As mentioned before this pair of basic 
l.- Am-Lys-Lys-At-g-Tyr-Tyr-Asp-Tyr-Asp-His 
2.- Tyr-Tyr-Asp-Tyr-Asp-His 
Fig. 3. NH*-terminal sequence of purified A-like form of ex- 
oglucanase secreted by the kex2 strain (1) as compared with that of the 
purified external exoglucanase (2). 
residues are cleaved at its carboxyl side by the past 
KEX2 protein. 
4. DISCUSSION 
In the present report we have presented results in- 
dicating that yeast exoglucanase is proteolytically pro- 
cessed during its transit to the cell surface. Two lines of 
evidence support a role for the KEX2 protein in such a 
processing. First, a kex2 mutant secretes an enzyme 
with an extrasequence of 4 amino acide bearing at its 
carboxyl end a pair of dibasic residues potentially 
cleavable by the protease. Second, a form of ex- 
oglucanase representative of the endoplasmic reticulum 
(form A) is proteolytically cleaved in vitro to give a pro- 
duct indistinguishable from the mature enzyme; this 
reaction did not proceed when form A was obtained in 
the presence of two inhibitors of KEX2 protease. As 
shown before, a similar, if not identical, processing also 
occurs in vivo and takes place before the execution 
point of sec7 mutation [14]. The fact that KEX2 pro- 
tease is also located in some compartment of the Golgi 
complex can thus be taken as additional circumstantial 
evidence of the action of this protease in the processing 
of the form A of exoglucanase in vivo. It should be 
noted that, in contrast to KEX2 protease, our in vitro 
transforming enzyme is soluble. This does not exclude 
the KEX2 protein from direct participation in the in 
vitro transformation since the only potential transmem- 
brane segment of KEX2 is located in the last 120 amino 
acids and KEX2 protease appears to present an 
autoproteolytic removal of about 100 amino acids [ 161. 
We should not forget, however, that previous studies 
have indicated the existence of yeast proteases other 
than KEX2, capable of cleaving not only artificial 
pheromone substrates [17,18] but also the MFa pro- 
pheromone itself at a cleavage site identical to that of 
the KEX2 protease [19]. 
In a previous work we have shown that both form A 
(isolated from a protoplast lysate) and the external ma- 
jor exoglucanase migrate very close in SDS-PAGE [ 141. 
We have also reported elsewhere [13] that the major 
yeast exoglucanase secreted into the culture medium 
contains about 27 mannoses and one phosphate (distri- 
buted in two short N-linked oligosaccharides) per 
molecule of enzyme. On the other hand, as a represen- 
tative of the endoplasmic reticulum, form A should 
contain 8 mannoses in each oligosaccharide [20]. The 
difference (11 mannoses plus one phosphate) accounts 
for a molecular mass of near 2000. This value is far 
above the molecular mass of the extrasequence found in 
the A-like form secreted by kex2 mutant (about 500) 
and it suggests the existence of an additional extrase- 
quence at the NHz-terminus in the form A present in the 
endoplasmic reticulum. Proteolytic cleavage (either in 
vivo or in vitro) at several sites of the extrasequence 
would be the source of the heterogeneity shown by the 
101 
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deglycosylated form A (Fig. 2, lane 1). Work is in pro- 
gress to isolate enough amounts of form A accumulated 
by secl8 in order to analyze its amino-terminus. 
In summary, the role of KEX2 protease in the pro- 
cessing of yeast precursors in vivo has now been extend- 
ed to the major exoglucanase from S. cerevisiae. We do 
not know yet whether the in vitro cleavage of ex- 
oglucanase is caused by KEX2 or a different protease. 
However, it is noticeable that the availability of a quan- 
titative and simple assay for this exoglucanase as well as 
the facility to separate the substrate {form A) from the 
product (form B) will allow a definitive characterization 
of the in vitro cleaving enzyme. 
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